10-K/A: Evergreen Corporation Files Amendment No. 1 to Form 10-K/A to Correct Audit Report Date

Evergreen Corporation filed an amendment to its annual report to correct the date of the independent registered public accounting firm's report and include updated certifications from its principal executive and financial officers.

Summary

• Evergreen Corporation filed Amendment No. 1 on Form 10-K/A to correct the date of the independent registered public accounting firm's report included in the original Form 10-K for the year ended November 30, 2024.
• The amendment also includes currently dated certifications from the company's principal executive officer and principal financial officer.
• The original Form 10-K was filed with the SEC on February 28, 2025.
• Except for the correction of the audit report date and the updated certifications, no other information in the original Form 10-K was amended, modified, or updated.
• As of May 31, 2024, the aggregate market value of the registrant's ordinary shares held by non-affiliates was $53,309,029.
• As of February 28, 2025, there were 2,739,800 Class A ordinary shares and 2,875,000 Class B ordinary shares issued and outstanding.

Sentiment

Score: 3

Explanation: The document presents a mixed picture, with some positive aspects like the merger agreement, but also significant concerns about the company's financial health, going concern status, and regulatory challenges. The delisting from Nasdaq and the material weakness in internal controls are particularly concerning.

Positives

• The company is pursuing a business combination with Forekast Limited, with an aggregate consideration of $105,000,000 payable in newly issued PubCo Ordinary Shares.
• The company has the right to extend the Combination Period up to six times for an additional one month each time from February 11, 2025 to August 11, 2025 by depositing into the trust account, for each one-month extension, $0.05 for each Class A ordinary share issued and outstanding after giving effect to the redemption.

Negatives

• The company's independent registered public accounting firm's report contains an explanatory paragraph that expresses substantial doubt about its ability to continue as a going concern.
• The company had a working capital deficit of $6,831,235 as of November 30, 2024.
• The company's securities have been delisted by Nasdaq and are now traded on the OTC Pink market, which could lead to reduced liquidity and other adverse consequences.
• The company's disclosure controls and procedures were not effective as of November 30, 2024, due to a material weakness in internal controls.

Risks

• The company may not be able to complete an initial business combination with a U.S. target company due to potential U.S. foreign investment regulations and review by CFIUS.
• The company's securities being traded on the over-the-counter market may make trading difficult for investors and potentially lead to declines in the share price.
• The company may face difficulties in raising additional capital due to its securities not being listed on a national securities exchange.
• The company's ability to continue as a going concern is subject to substantial doubt due to its liquidity condition and mandatory liquidation date.

Future Outlook

The company is focused on completing a business combination with Forekast Limited and may seek additional extensions to the Combination Period.

Industry Context

The document pertains to a special purpose acquisition company (SPAC) navigating the challenges of completing a business combination within a specified timeframe, including seeking extensions and dealing with potential regulatory hurdles.

Comparison to Industry Standards

• SPACs typically aim to complete a business combination within 12-24 months of their IPO.
• The document highlights the company's efforts to extend its Combination Period, a common practice among SPACs facing difficulties in finding suitable targets.
• The redemptions by shareholders are a common occurrence in the SPAC market, especially when the initial enthusiasm wanes or when a proposed merger is viewed unfavorably.
• The delisting from Nasdaq and subsequent trading on the OTC Pink market is a negative development, as it reduces liquidity and visibility, similar to other SPACs that have failed to meet listing requirements.

Related Party Transactions

• The company agreed to pay the Sponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support from the date of the company's initial public offering until consummation of its initial business combination.
• In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company's officers and directors may, but are not obligated to, loan the Company funds as may be required (Working Capital Loans).

Stakeholder Impact

• Shareholders face the risk of liquidation if the business combination is not completed.
• Shareholders may experience reduced liquidity and potential price declines due to the delisting from Nasdaq.
• Creditors face the risk of not being fully repaid if the company liquidates.
• Employees of the target company face uncertainty regarding their future employment.

Next Steps

• The company needs to complete the business combination with Forekast Limited.
• The company needs to address the material weakness in internal controls.
• The company needs to regain compliance with listing requirements or find a suitable exchange for its securities.

Key Dates